Updated on 6 May 2016
Asia Pacific: Venture funding globally reached a record of $4.5 billion in 2015, quadrupling that of 2011, but only up 4% from 2014 (USD4.3 billion, 295 deals). Funding is therefore likely to reach a phase of continued maturing in2016, according to Baker & McKenzie's latest report "Powering the Future of Healthcare in Asia Pacific," which looks at the global trends and the legal environment concerning healthtech funding, as well as the Asia healthtech landscape.
China, India and Singapore as the hotbeds for healthtech start-ups
The last three years have seen a surge in healthtechstart-ups in the Asia Pacific region, driven among others by a growing middle class affluence and health awareness, the need for chronic disease management, and the growing demand for senior healthcare products and services. China, India and Singapore have become hotbeds for healthtech start-ups in the region, with most of these start-ups falling under the categories of "Navigating the Healthcare System," "Patient Engagement" and"Consumer Health and Wellness."
Although more than 100 accelerators/ incubators were launched across Asia Pacific within the same period, few are healthtech focused although this trend is expected to change in the next 12 months, according to the Report. Corporates and strategics have also begun stepping into the Asia healthtech sector, with insurance companies leading the charge. AIA Accelerator (powered by Nest) ran its first cohort of eight healthtech start-ups in 2015, which attracted 76 applications from 16 countries. Metlife has launched its own internal incubator, Lumen Lab, which has a deliberate healthtech focus.
Wearables on personal health tracking on the rise